|
EPB41L4B expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.44089209850063E-16 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.25120041999583E-10 |
| Normal-vs-Stage2 |
1.60980007102296E-10 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
2.50569998083705E-09 |
| Stage1-vs-Stage2 |
4.474800E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
5.146800E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
9.664400E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
4.488600E-01 |
| Normal-vs-Asian |
4.04000000009397E-07 |
| Caucasian-vs-AfricanAmerican |
5.672600E-01 |
| Caucasian-vs-Asian |
8.020400E-02 |
| AfricanAmerican-vs-Asian |
4.662000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.42663658664333E-13 |
| Normal-vs-Female |
7.51290141209893E-11 |
| Male-vs-Female |
8.388400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.58110035753634E-10 |
| Normal-vs-Extreme_Weight |
3.28626015289046E-14 |
| Normal-vs-Obese |
1.76455999999492E-05 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
7.996400E-01 |
| Normal_Weight-vs-Obese |
2.212600E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
1.899030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.86790000000459E-05 |
| Normal-vs-Age(41-60Yrs) |
1.06010000000545E-07 |
| Normal-vs-Age(61-80Yrs) |
2.33146835171283E-15 |
| Normal-vs-Age(81-100Yrs) |
1.8904099999939E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.780000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.818800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.604400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.066000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.508800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.012800E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
6.746600E-01 |
| Normal-vs-Grade 3 |
6.465000E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
8.078200E-01 |
| Grade 2-vs-Grade 4 |
6.746600E-01 |
| Grade 3-vs-Grade 4 |
6.465000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.8544055180314E-12 |
| Normal-vs-N1 |
1.48390000287435E-08 |
| N0-vs-N1 |
8.733800E-01 |
|
|
